Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/PERSEUS-PROTEOMICS-INC-103499488/attualita/Perseus-Proteomics-Inc-annuncia-l-estensione-dello-studio-clinico-di-Fase-I-di-PPMX-T003-tra-i-pazi-42917308/?utm_source=whatsapp&utm_medium=social&utm_campaign=share